ReviewPharmaceuticals (Basel, Switzerland)2024
PCSK9 Inhibitors: Focus on Evolocumab and Its Impact on Atherosclerosis Progression.
Maram H AbduljabbarPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it